Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study-Reference-Cited by-同舟云学术

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

Published:2022-09 Issue: Volume:20 Page:100438
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Sundström Johan^ORCID,Bodegard Johan^ORCID,Bollmann Andreas,Vervloet Marc G.,Mark Patrick B.^ORCID,Karasik Avraham,Taveira-Gomes Tiago^ORCID,Botana Manuel^ORCID,Birkeland Kåre I.,Thuresson Marcus,Jäger Levy^ORCID,Sood Manish M.^ORCID,VanPottelbergh Gijs,Tangri Navdeep

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference13 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Bikbov;Lancet,2020

2. Global prevalence of chronic kidney disease - a systematic review and meta-analysis;Hill;PLoS One,2016

3. Chronic Kidney Disease Basics | Chronic Kidney Disease Initiative | CDC. published online Sept 13. https://www.cdc.gov/kidneydisease/basics.html. 2021. Accessed 23 November 2021.

4. All-cause costs increase exponentially with increased chronic kidney disease stage;Golestaneh;Am J Manag Care,2017

5. Identification of patients with CKD in medical databases: a comparison of different algorithms;Vestergaard;Clin J Am Soc Nephrol,2021

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary biomarkers in kidney disease;Clinica Chimica Acta;2024-03

2. The protective effect and mechanism of piperazine ferulate in rats with 5/6 nephrectomy-caused chronic kidney disease;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-02

3. Ni-based metal-organic framework sensor material for urea detection: Mechanistic insights and performance;Electrochimica Acta;2024-02

4. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan;Advances in Therapy;2024-01-19

5. Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data;Journal of Nephrology;2024-01-18